Currently, there are 76.32M common shares owned by the public and among those 74.31M shares have been available to trade.
Insiders at the company have transacted a total of 38 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 19 of these insider trades were purchases, accounting for 297,587 shares. Insider sales of the common stock occurred on 19 occasions, with total insider shares sold totaling 11,369 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
However, the script later moved the day high at 15.01, up 15.56%. The company’s stock has a 5-day price change of 26.70% and 56.78% over the past three months. ASPN shares are trading -9.19% year to date (YTD), with the 12-month market performance up to 37.52% higher. It has a 12-month low price of $5.32 and touched a high of $17.32 over the same period. ASPN has an average intraday trading volume of 5.77 shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 21.25%, 10.60%, and 60.05% respectively.
Institutional ownership of Aspen Aerogels Inc. (NYSE: ASPN) shares accounts for 91.02% of the company’s 76.32M shares outstanding.
It has a market capitalization of $1.09B and a beta (3y monthly) value of 1.94. The earnings-per-share (ttm) stands at -$0.66. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.80% over the week and 5.66% over the month.
Earnings per share for the fiscal year are expected to increase by 72.01%, and 429.85% over the next financial year.
Looking at the support for the ASPN, a number of firms have released research notes about the stock. The Benchmark Company stated their Buy rating for the stock in a research note on March 20, 2023, with the firm’s price target at $14.
